SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007127
Filing Date
2023-10-13
Accepted
2023-10-13 10:20:32
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT canna_i10q-063023.htm   iXBRL 10-Q 803086
2 CERTIFICATION canna_ex3101.htm EX-31.1 11488
3 CERTIFICATION canna_ex3102.htm EX-31.2 11491
4 CERTIFICATION canna_ex3200.htm EX-32 4497
  Complete submission text file 0001683168-23-007127.txt   3876105

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20230630.xsd EX-101.SCH 32157
6 XBRL CALCULATION FILE cpmd-20230630_cal.xml EX-101.CAL 54202
7 XBRL DEFINITION FILE cpmd-20230630_def.xml EX-101.DEF 115610
8 XBRL LABEL FILE cpmd-20230630_lab.xml EX-101.LAB 237146
9 XBRL PRESENTATION FILE cpmd-20230630_pre.xml EX-101.PRE 205141
54 EXTRACTED XBRL INSTANCE DOCUMENT canna_i10q-063023_htm.xml XML 439358
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 231324128
SIC: 2834 Pharmaceutical Preparations